Mirae Asset Global ETFs Holdings’s Stoke Therapeutics STOK Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.1M	Buy	33,873 +1,358	+4%	+$44.5K	﹤0.01%	1475
2025 Q4	$1.03M	Sell	32,515 -17,948	-36%	-$540K	﹤0.01%	1499
2025 Q3	$1.19M	Sell	50,463 -2,948	-6%	-$50.5K	﹤0.01%	1387
2025 Q2	$607K	Buy	53,411 +29,244	+121%	+$278K	﹤0.01%	1714
2025 Q1	$162K	Buy	24,167 +1,149	+5%	+$10.7K	﹤0.01%	2417
2024 Q4	$253K	Buy	23,018 +313	+1%	+$3.85K	﹤0.01%	2262
2024 Q3	$279K	Buy	22,705 +5,054	+29%	+$71.6K	﹤0.01%	2199
2024 Q2	$238K	Buy	+17,651	New	+$238K	﹤0.01%	2164

Other funds holding STOK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's STOK Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Stoke Therapeutics (STOK) stake by 4.2% in Q1 2026, buying an estimated $44.5K and bringing the position to 33,873 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1475.

Mirae Asset Global ETFs Holdings first reported a position in STOK in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.19M in Q3 2025. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

Mirae Asset Global ETFs Holdings held 33,873 shares of Stoke Therapeutics worth $1.1M as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 1,358 Stoke Therapeutics shares in Q1 2026, an estimated $44.5K.
Stoke Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1475 holding.
Mirae Asset Global ETFs Holdings first reported a position in Stoke Therapeutics in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Stoke Therapeutics position peaked at $1.19M in Q3 2025.
196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.